Malignant Germ Cell Tumor — Trials

Malignant Germ Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 44
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 101–114 of 114 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00929903	Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment	completed	Phase 1	55	National Cancer Institute (NCI)NIH	1	Sep 30, 2013	clinicaltrials
NCT00012181	Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Jul 2, 2013	clinicaltrials